ATE244558T1 - Trockene formbare arzneistoffformulierung - Google Patents
Trockene formbare arzneistoffformulierungInfo
- Publication number
- ATE244558T1 ATE244558T1 AT00918719T AT00918719T ATE244558T1 AT E244558 T1 ATE244558 T1 AT E244558T1 AT 00918719 T AT00918719 T AT 00918719T AT 00918719 T AT00918719 T AT 00918719T AT E244558 T1 ATE244558 T1 AT E244558T1
- Authority
- AT
- Austria
- Prior art keywords
- drug formulation
- dry
- moldable drug
- dry moldable
- cannulas
- Prior art date
Links
- 239000013583 drug formulation Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 241001631457 Cannula Species 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA199900514 | 1999-04-16 | ||
| PCT/DK2000/000184 WO2000062759A1 (en) | 1999-04-16 | 2000-04-13 | Dry, mouldable drug formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE244558T1 true ATE244558T1 (de) | 2003-07-15 |
Family
ID=8094419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00918719T ATE244558T1 (de) | 1999-04-16 | 2000-04-13 | Trockene formbare arzneistoffformulierung |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US7666844B2 (de) |
| EP (1) | EP1173151B1 (de) |
| JP (1) | JP2002542183A (de) |
| AT (1) | ATE244558T1 (de) |
| AU (1) | AU3957400A (de) |
| DE (1) | DE60003803T2 (de) |
| WO (1) | WO2000062759A1 (de) |
Families Citing this family (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
| JP2002542183A (ja) | 1999-04-16 | 2002-12-10 | ノボ ノルディスク アクティーゼルスカブ | 成形可能な乾燥した医薬製剤 |
| EP1274720A4 (de) | 2000-04-12 | 2004-08-18 | Human Genome Sciences Inc | Albumin enthaltende fusionsproteine |
| WO2002005744A1 (en) * | 2000-07-14 | 2002-01-24 | Novo Nordisk A/S | Method of moulding a pharmaceutical composition in a packaging material |
| ES2333849T3 (es) | 2001-04-20 | 2010-03-02 | Alza Corporation | Disposicion de microsalientes que presenta un revestimiento que contiene un agente beneficioso. |
| US20020193729A1 (en) | 2001-04-20 | 2002-12-19 | Cormier Michel J.N. | Microprojection array immunization patch and method |
| EP3251722B1 (de) | 2001-04-20 | 2020-06-17 | ALZA Corporation | Mikroprojektionsanordnung mit einer beschichtung, der ein vorteilhaftes mittel enthält und beschichtungsverfahren dafuer |
| US8454997B2 (en) * | 2001-12-18 | 2013-06-04 | Novo Nordisk A/S | Solid dose micro implant |
| EP1458352A1 (de) * | 2001-12-18 | 2004-09-22 | Novo Nordisk A/S | Festdosis-mikroimplantat |
| PT1463751E (pt) | 2001-12-21 | 2013-08-26 | Human Genome Sciences Inc | Proteínas de fusão de albumina |
| CA2513213C (en) | 2003-01-22 | 2013-07-30 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| CA2566079A1 (en) | 2004-05-12 | 2005-12-01 | Terrence L. Scott | Nucleic acid microspheres, production and delivery thereof |
| WO2005112885A2 (en) | 2004-05-12 | 2005-12-01 | Baxter International Inc. | Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1 |
| US8728525B2 (en) | 2004-05-12 | 2014-05-20 | Baxter International Inc. | Protein microspheres retaining pharmacokinetic and pharmacodynamic properties |
| EP1753404A1 (de) | 2004-05-12 | 2007-02-21 | Baxter International Inc. | Mikrokügelchen mit protein; die bei hohen konzentrationen des mittels injizierbar sind |
| US7249525B1 (en) | 2005-06-22 | 2007-07-31 | Cidra Corporation | Apparatus for measuring parameters of a fluid in a lined pipe |
| EP2647712A3 (de) | 2006-08-04 | 2013-11-20 | Baxter International Inc | Zusammensetzung auf Mikrokügelchenbasis zur Vorbeugung und/oder Umkehrung einer Neuerkrankung an autoimmun bedingter Diabetes |
| JP5623743B2 (ja) | 2006-10-20 | 2014-11-12 | アムジエン・インコーポレーテツド | 安定なポリペプチド製剤 |
| GB2446780A (en) | 2007-02-22 | 2008-08-27 | Glide Pharmaceutical Technolog | An elongate parenteral injection body having an injection point of angle 10 to 40 degrees. |
| CA2682135A1 (en) | 2007-04-17 | 2008-10-30 | Baxter International Inc. | Nucleic acid microparticles for pulmonary delivery |
| EP2674417A3 (de) | 2007-11-21 | 2014-04-09 | Decode Genetics EHF | Biaryl-PDE4-Inhibitoren zur Behandlung von Entzündungen |
| BRPI0907122B8 (pt) | 2008-01-11 | 2021-05-25 | Albany Molecular Res Inc | compostos de piridoindóis (1-azinona) substituídos, composição farmacêutica compreendendo os referidos compostos, e usos dos mesmos |
| WO2010059836A1 (en) | 2008-11-20 | 2010-05-27 | Decode Genetics Ehf | Substituted aza-bridged bicyclics for cardiovascular and cns disease |
| CA2750777C (en) | 2009-01-26 | 2018-04-03 | Israel Institute For Biological Research | Bicyclic heterocyclic spiro compounds |
| WO2010093834A2 (en) * | 2009-02-12 | 2010-08-19 | Incube Labs, Llc | Skin penetrating device and method for subcutaneous solid drug delivery |
| US8562589B2 (en) | 2009-12-24 | 2013-10-22 | Rani Therapeutics, Llc | Swallowable drug delivery device and method of delivery |
| MX345693B (es) * | 2010-03-01 | 2017-02-10 | Wrigley W M Jun Co | Material incrementador de volumen amorfo de goma de mascar. |
| JP5931757B2 (ja) | 2010-03-10 | 2016-06-08 | インキューブ ラブズ， エルエルシー | 嚥下可能な薬物送達デバイスを用いた腸管の内腔への送達のための治療薬調製物 |
| CN103003422B (zh) | 2010-04-20 | 2015-02-11 | 奥克塔法马股份有限公司 | 用于药物蛋白的新型稳定剂 |
| US8980822B2 (en) | 2010-12-23 | 2015-03-17 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9402806B2 (en) | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9415004B2 (en) | 2010-12-23 | 2016-08-16 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9861683B2 (en) | 2010-12-23 | 2018-01-09 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9259386B2 (en) | 2010-12-23 | 2016-02-16 | Rani Therapeutics, Llc | Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9284367B2 (en) | 2010-12-23 | 2016-03-15 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9629799B2 (en) | 2010-12-23 | 2017-04-25 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8809269B2 (en) | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8734429B2 (en) | 2010-12-23 | 2014-05-27 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US10639272B2 (en) | 2010-12-23 | 2020-05-05 | Rani Therapeutics, Llc | Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8969293B2 (en) | 2010-12-23 | 2015-03-03 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9283179B2 (en) | 2010-12-23 | 2016-03-15 | Rani Therapeutics, Llc | GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9402807B2 (en) | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| CA2853112C (en) | 2011-10-25 | 2018-08-21 | Onclave Therapeutics Limited | Antibody formulations and methods |
| US10722458B2 (en) * | 2011-12-02 | 2020-07-28 | Pegasus Laboratories, Inc. | Amphipathic lipid-based sustained release compositions |
| EP2968162B1 (de) * | 2013-03-15 | 2020-12-02 | Incube Labs, Llc | Biologisch abbaubare plattform zur mehrstufigen wirkstoffabgabe |
| CA2949236C (en) | 2014-05-15 | 2023-06-13 | Incube Labs, Llc | Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins |
| US11548940B2 (en) | 2014-05-15 | 2023-01-10 | Rani Therapeutics, Llc | Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US10689460B2 (en) | 2014-05-15 | 2020-06-23 | Incube Labs, Llc | PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| WO2016079330A1 (en) | 2014-11-21 | 2016-05-26 | Technical University Of Denmark | Gel formulations for local drug release |
| FR3034418B1 (fr) * | 2015-04-03 | 2018-09-28 | Roquette Freres | Utilisation de combinaisons particulieres de carbohydrates pour stabiliser des proteines, et compositions proteiques contenant de telles combinaisons |
| EP3288543A4 (de) | 2015-05-01 | 2018-11-14 | Incube Labs, LLC | Pharmazeutische zusammensetzungen und verfahren zur herstellung fester massen mit polypeptiden und/oder proteinen |
| US11541015B2 (en) | 2017-05-17 | 2023-01-03 | Massachusetts Institute Of Technology | Self-righting systems, methods, and related components |
| CA3063711A1 (en) | 2017-05-17 | 2018-11-22 | Massachusetts Institute Of Technology | Self-righting systems, methods, and related components |
| AU2019240065A1 (en) | 2018-03-20 | 2020-09-24 | Icahn School Of Medicine At Mount Sinai | Kinase inhibitor compounds and compositions and methods of use |
| TWI829687B (zh) | 2018-05-07 | 2024-01-21 | 丹麥商諾佛 儂迪克股份有限公司 | 包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物 |
| EP3793667A1 (de) | 2018-05-17 | 2021-03-24 | Massachusetts Institute of Technology | Systeme zur elektrischen stimulation |
| CA3124700A1 (en) | 2018-12-31 | 2020-07-09 | Icahn School Of Medicine At Mount Sinai | Kinase inhibitor compounds and compositions and methods of use |
| WO2020160399A1 (en) | 2019-02-01 | 2020-08-06 | Massachusetts Institute Of Technology | Systems and methods for liquid injection |
| GB201909280D0 (en) * | 2019-06-27 | 2019-08-14 | Enesi Pharma Ltd | Solid dose formulation |
| US11541216B2 (en) | 2019-11-21 | 2023-01-03 | Massachusetts Institute Of Technology | Methods for manufacturing tissue interfacing components |
Family Cites Families (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US202072A (en) | 1878-04-02 | Improvement in stands for casks or barrels | ||
| US577107A (en) * | 1897-02-16 | leayitt | ||
| US615490A (en) * | 1897-10-01 | 1898-12-06 | Headlight-reflector | |
| US4015033A (en) | 1972-02-24 | 1977-03-29 | Imperial Chemical Industries Limited | Laminates of acrylonitrile/styrene copolymers |
| US3948263A (en) | 1974-08-14 | 1976-04-06 | Minnesota Mining And Manufacturing Company | Ballistic animal implant |
| US4089334A (en) | 1976-10-07 | 1978-05-16 | Schwebel Paul R | Pyrotechnically powered needleless injector |
| US4153406A (en) | 1978-04-25 | 1979-05-08 | Amp Incorporated | Stripper ring for a capsule-making machine |
| US4326524A (en) | 1980-09-30 | 1982-04-27 | Minnesota Mining And Manufacturing Company | Solid dose ballistic projectile |
| GB2091554B (en) | 1981-01-13 | 1984-09-12 | Mitsui Toatsu Chemicals | Rod like moulded drug |
| US4576604A (en) * | 1983-03-04 | 1986-03-18 | Alza Corporation | Osmotic system with instant drug availability |
| CA1196864A (en) | 1983-06-10 | 1985-11-19 | Mattheus F.A. Goosen | Controlled release of injectable and implantable insulin compositions |
| US6309669B1 (en) | 1984-03-16 | 2001-10-30 | The United States Of America As Represented By The Secretary Of The Army | Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix |
| US4697575A (en) | 1984-11-21 | 1987-10-06 | Henry Ford Hospital | Delivery system for interstitial radiation therapy including substantially non-deflecting elongated member |
| US4671953A (en) | 1985-05-01 | 1987-06-09 | University Of Utah Research Foundation | Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics |
| US4962091A (en) | 1986-05-23 | 1990-10-09 | Syntex (U.S.A.) Inc. | Controlled release of macromolecular polypeptides |
| FI81494C (fi) | 1987-12-30 | 1990-11-12 | Huhtamaeki Oy | Kasettsystem och anordning foer framstaellning av subkutan preventivkapsel. |
| US5372590A (en) | 1990-07-27 | 1994-12-13 | Habley Medical Technology Corporation | Multi-celled safety package, needle guard and safety disposal module with sleeve for prefilled medication cartridges |
| HUT69680A (en) | 1990-08-09 | 1995-09-28 | Endocon Inc | Implant and apparatus for delivering multiple drug and process for production of theese |
| IE920040A1 (en) | 1991-01-09 | 1992-07-15 | Alza Corp | Bioerodible devices and compositions for diffusional release¹of agents |
| US5153002A (en) | 1991-03-04 | 1992-10-06 | University Of Montreal | Biocompatible gradient controlled release implant |
| US5486362A (en) | 1991-05-07 | 1996-01-23 | Dynagen, Inc. | Controlled, sustained release delivery system for treating drug dependency |
| US5403595A (en) | 1991-05-07 | 1995-04-04 | Dynagen, Inc. | Controlled, sustained release delivery system for smoking cessation |
| HU222501B1 (hu) | 1991-06-28 | 2003-07-28 | Endorecherche Inc. | MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására |
| DK0615438T3 (da) | 1991-12-05 | 1996-11-11 | Mallinckrodt Veterinary Inc | En carbohydratglasmatrix til langvarig frigivelse af et terapeutisk middel |
| US5543154A (en) * | 1991-12-27 | 1996-08-06 | Merck & Co., Inc. | Controlled release nifedipine delivery device |
| WO1993012765A1 (en) | 1991-12-27 | 1993-07-08 | Merck & Co., Inc. | A controlled release drug dispersion delivery device |
| WO1993017662A1 (en) | 1992-03-02 | 1993-09-16 | Daratech Pty. Ltd. | Improved implants |
| US5429822A (en) | 1992-03-13 | 1995-07-04 | Cambridge Scientific, Inc. | Biodegradable bursting release system |
| NL9200844A (nl) | 1992-05-13 | 1993-12-01 | De Wijdeven Gijsbertus G P Van | Inrichting en werkwijze voor het injecteren met een vaste stof. |
| AU4932493A (en) | 1992-09-25 | 1994-04-26 | Dynagen, Inc. | An immunobooster for delayed release of immunogen |
| GR1001437B (el) | 1992-11-05 | 1993-12-30 | Aggelos Kontos | Ζαχαροπλαστικό σύστημα χορηγήσεως φαρμακολογικώς δραστικών ουσιών. |
| DK42093D0 (da) * | 1993-04-07 | 1993-04-07 | Bukh Meditec | Administrationsmetode |
| TW360548B (en) | 1993-04-08 | 1999-06-11 | Powderject Res Ltd | Products for therapeutic use |
| JPH06321803A (ja) | 1993-05-17 | 1994-11-22 | Kirin Brewery Co Ltd | 水溶性ペプチドホルモンの徐放性製剤 |
| US5716981A (en) | 1993-07-19 | 1998-02-10 | Angiogenesis Technologies, Inc. | Anti-angiogenic compositions and methods of use |
| US6176874B1 (en) | 1993-10-18 | 2001-01-23 | Masschusetts Institute Of Technology | Vascularized tissue regeneration matrices formed by solid free form fabrication techniques |
| JP3720386B2 (ja) | 1993-12-27 | 2005-11-24 | 住友製薬株式会社 | 薬物放出制御製剤 |
| DE4406172C2 (de) | 1994-02-25 | 2003-10-02 | Sanol Arznei Schwarz Gmbh | Polyester |
| US5567439A (en) | 1994-06-14 | 1996-10-22 | Fuisz Technologies Ltd. | Delivery of controlled-release systems(s) |
| US5633000A (en) | 1994-06-23 | 1997-05-27 | Axxia Technologies | Subcutaneous implant |
| US6290991B1 (en) | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
| DE69531992T2 (de) * | 1994-08-04 | 2004-07-22 | Elan Drug Delivery Ltd., Ruddington | Feste verabreichungssysteme zur gesteuerten freisetzung von darin eingebauten molekülen sowie verfahren zu deren herstellung |
| US5582591A (en) | 1994-09-02 | 1996-12-10 | Delab | Delivery of solid drug compositions |
| US5595760A (en) | 1994-09-02 | 1997-01-21 | Delab | Sustained release of peptides from pharmaceutical compositions |
| US5837276A (en) | 1994-09-02 | 1998-11-17 | Delab | Apparatus for the delivery of elongate solid drug compositions |
| US5542920A (en) | 1994-09-12 | 1996-08-06 | Delab | Needle-less parenteral introduction device |
| DK0783342T3 (da) | 1994-09-27 | 1999-07-19 | Delab | Sikkerhedsindsprøjtningsindretning |
| US6231904B1 (en) | 1995-03-08 | 2001-05-15 | Martin Mueller | Frozen confection package with novelty ink stamp |
| US5762961A (en) | 1996-02-09 | 1998-06-09 | Quadrant Holdings Cambridge Ltd. | Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof |
| US5833891A (en) | 1996-10-09 | 1998-11-10 | The University Of Kansas | Methods for a particle precipitation and coating using near-critical and supercritical antisolvents |
| US5874029A (en) | 1996-10-09 | 1999-02-23 | The University Of Kansas | Methods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent |
| US5823994A (en) | 1996-03-15 | 1998-10-20 | Oratec Interventions, Inc. | Method and apparatus for soft tissue fixation |
| US5817343A (en) | 1996-05-14 | 1998-10-06 | Alkermes, Inc. | Method for fabricating polymer-based controlled-release devices |
| EP0910348B1 (de) | 1996-05-23 | 2003-04-02 | Samyang Corporation | Lokal verabreichbares biologisch abbaubares arzneimittel mit verzögerter frei-setzung für periodontitis und verfahren zu dessen herstellung |
| US6143037A (en) | 1996-06-12 | 2000-11-07 | The Regents Of The University Of Michigan | Compositions and methods for coating medical devices |
| US5980948A (en) | 1996-08-16 | 1999-11-09 | Osteotech, Inc. | Polyetherester copolymers as drug delivery matrices |
| US5945128A (en) | 1996-09-04 | 1999-08-31 | Romano Deghenghi | Process to manufacture implants containing bioactive peptides |
| US5766637A (en) | 1996-10-08 | 1998-06-16 | University Of Delaware | Microencapsulation process using supercritical fluids |
| IT1290425B1 (it) | 1996-10-22 | 1998-12-03 | Dott Bonapace & C Srl | Dispositivo dosatore di sostanze pulverulente per macchine per il riempimento di opercoli |
| US6515016B2 (en) | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
| US20020111603A1 (en) | 1996-12-02 | 2002-08-15 | Societe De Conseils De Recherches Et D'application | Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process |
| DE19651237A1 (de) | 1996-12-10 | 1998-06-18 | Bosch Gmbh Robert | Vorrichtung zum Dosieren und Abgeben von Pulver in Hartgelatinekapseln od. dgl. |
| DE69717143T2 (de) * | 1996-12-20 | 2003-10-02 | E.I. Du Pont De Nemours And Co., Wilmington | Zusammensetzung enthaltend flüssigkristallines polymer |
| US5776107A (en) | 1996-12-31 | 1998-07-07 | Delab | Injection device |
| US5783567A (en) | 1997-01-22 | 1998-07-21 | Pangaea Pharmaceuticals, Inc. | Microparticles for delivery of nucleic acid |
| US6232340B1 (en) | 1997-04-24 | 2001-05-15 | Angiotech Pharmaceuticals, Inc. | Vanadium complexes and derivatives thereof and methods related thereto |
| US6241771B1 (en) | 1997-08-13 | 2001-06-05 | Cambridge Scientific, Inc. | Resorbable interbody spinal fusion devices |
| US6201072B1 (en) | 1997-10-03 | 2001-03-13 | Macromed, Inc. | Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
| US6117949A (en) | 1998-10-01 | 2000-09-12 | Macromed, Inc. | Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
| US6004573A (en) | 1997-10-03 | 1999-12-21 | Macromed, Inc. | Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
| US6352722B1 (en) * | 1997-12-23 | 2002-03-05 | Quadrant Holdings Cambridge Limited | Derivatized carbohydrates, compositions comprised thereof and methods of use thereof |
| EP1064353B1 (de) | 1998-03-18 | 2002-11-06 | Massachusetts Institute Of Technology | Vaskularisierte perfundierte anordnungen für mikrogewebe und mikroorgane |
| US6224794B1 (en) | 1998-05-06 | 2001-05-01 | Angiotech Pharmaceuticals, Inc. | Methods for microsphere production |
| US6224630B1 (en) | 1998-05-29 | 2001-05-01 | Advanced Bio Surfaces, Inc. | Implantable tissue repair device |
| US6149864A (en) | 1998-06-25 | 2000-11-21 | Massachusetts Institute Of Technology | Supercritical fluid sterilization method |
| US20020005367A1 (en) | 1998-11-25 | 2002-01-17 | Steve Terry Zelson | Coffee filter holder |
| AU770235B2 (en) | 1999-03-08 | 2004-02-19 | Powderject Research Limited | Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds |
| US6485453B1 (en) | 1999-04-16 | 2002-11-26 | Novo Nordisk A/S | Cassette for storing and insertion of solid medicine |
| JP2002542183A (ja) | 1999-04-16 | 2002-12-10 | ノボ ノルディスク アクティーゼルスカブ | 成形可能な乾燥した医薬製剤 |
| AU1622801A (en) | 1999-11-18 | 2001-05-30 | Regents Of The University Of Michigan, The | Sustained drug delivery from structural matrices |
| WO2001037804A2 (en) | 1999-11-22 | 2001-05-31 | Universal Preservation Technologies, Inc. | Preservation and formulation of bioactive materials |
| WO2002005744A1 (en) | 2000-07-14 | 2002-01-24 | Novo Nordisk A/S | Method of moulding a pharmaceutical composition in a packaging material |
| US7615234B2 (en) | 2001-09-11 | 2009-11-10 | Glide Pharmaceutical Technologies Limited | Drug delivery technology |
| US8454997B2 (en) | 2001-12-18 | 2013-06-04 | Novo Nordisk A/S | Solid dose micro implant |
| EP2081018A1 (de) | 2008-01-18 | 2009-07-22 | F.Hoffmann-La Roche Ag | Gassensor mit mikroporöser Elektrolytschicht |
-
2000
- 2000-04-13 JP JP2000611896A patent/JP2002542183A/ja not_active Withdrawn
- 2000-04-13 DE DE60003803T patent/DE60003803T2/de not_active Expired - Lifetime
- 2000-04-13 WO PCT/DK2000/000184 patent/WO2000062759A1/en not_active Ceased
- 2000-04-13 AU AU39574/00A patent/AU3957400A/en not_active Abandoned
- 2000-04-13 AT AT00918719T patent/ATE244558T1/de not_active IP Right Cessation
- 2000-04-13 EP EP00918719A patent/EP1173151B1/de not_active Expired - Lifetime
-
2005
- 2005-02-07 US US11/052,645 patent/US7666844B2/en not_active Expired - Fee Related
-
2009
- 2009-08-07 US US12/462,794 patent/US8084053B2/en not_active Expired - Fee Related
-
2011
- 2011-10-31 US US13/285,470 patent/US8518430B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE60003803D1 (de) | 2003-08-14 |
| WO2000062759A1 (en) | 2000-10-26 |
| DE60003803T2 (de) | 2004-06-03 |
| US8518430B2 (en) | 2013-08-27 |
| JP2002542183A (ja) | 2002-12-10 |
| US7666844B2 (en) | 2010-02-23 |
| EP1173151B1 (de) | 2003-07-09 |
| AU3957400A (en) | 2000-11-02 |
| US8084053B2 (en) | 2011-12-27 |
| US20100196477A1 (en) | 2010-08-05 |
| EP1173151A1 (de) | 2002-01-23 |
| US20050202072A1 (en) | 2005-09-15 |
| US20120082724A1 (en) | 2012-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60003803D1 (de) | Trockene formbare arzneistoffformulierung | |
| DE60017831D1 (de) | Dermale zusammensetzungen | |
| GEP20063799B (en) | Tropane derivatives useful in therapy | |
| ATE298562T1 (de) | Hydrogelpartikel formulierungen | |
| BR0113643A (pt) | Compostos de guanidinobenzamidas como agonistas de mc4-r e seus usos | |
| SE0003984D0 (sv) | Adenosin A3-receptormodulatorer | |
| BR0107869A (pt) | Composições farmacêuticas eletrogiradas | |
| MY119403A (en) | Novel compounds with analgesic effect. | |
| BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
| DE69931925D1 (de) | 2-chinolonen enthaltende arzneimittel | |
| AU2002211536A1 (en) | Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals | |
| DE60023107D1 (de) | Zubereitungen mit verbesserter kontrollierter freisetzung | |
| SE9900961D0 (sv) | Novel compounds | |
| ATE280583T1 (de) | Stabilisierte pharmazeutische zusammentsetzung in lyophilisierter form | |
| IL150953A0 (en) | A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer | |
| BR0001201A (pt) | Composto ( poli ) tia-alcinóicos, composição cosmética, utilização de uma composição cosmética, utilização de um composto e composição farmacêutica | |
| GEP20043225B (en) | 1-Trifluoromethyl-4-Hydroxy-7- Piperidinyl-Aminomethylchroman Derivatives | |
| DE60023307D1 (de) | Phenanthrolin-7-onderivate und ihre therapeutische verwendung | |
| PT1202992E (pt) | Derivados de ascididemina e suas aplicacoes terapeuticas | |
| EA200300368A1 (ru) | Применение аргинина при получении лекарственного средства для профилактики и лечения побочных эффектов, связанных с внутривенным введением фармацевтических препаратов | |
| FR2801220B1 (fr) | Dispositif d'injection de substances pharmaceutiques avec melange prealable | |
| FR2800276B1 (fr) | Composition et medicament, notamment anti-inflammatoire, constitue de ladite composition | |
| ITFI990054A0 (it) | Dispositivo di protezione per l'ago di siringhe per iniezioni atto ad evitare il rischio di offese causate dalle punta dell'ago |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |